Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$943,833,942
+$227,188,712 QoQ
Shares Held
786,902
+1.0% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
1.06%
of 13F equity value
Holder Rank
#85
of 4,632 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 84%
Shared 0%
None 15%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STIFEL FINANCIAL CORP holds $5,426,093,696 across 17 Drug Manufacturers - General names. LLY ranks #3 (17.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,454,737 | $1,131,369,551 | |
| 2 | MRK |
Merck & Co., Inc.
|
8,169,394 | $1,049,767,127 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
786,902 | $943,833,942 | |
| 4 | ABBV |
AbbVie Inc.
|
3,625,155 | $912,234,002 | |
| 5 | AMGN |
Amgen Inc
|
1,548,229 | $560,644,681 | |
| 6 | PFE |
Pfizer Inc
|
9,980,325 | $240,326,222 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,152,519 | $145,609,245 | |
| 8 | AZN |
Astrazeneca PLC
|
670,847 | $127,206,004 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $943,833,942 | 786,902 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $716,645,230 | 779,157 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $852,856,453 | 793,591 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $602,897,421 | 790,167 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $644,476,424 | 826,750 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $668,680,684 | 809,629 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $617,149,152 | 799,416 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $659,252,757 | 744,128 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $661,111,189 | 730,203 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $566,343,207 | 727,985 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $417,554,919 | 716,316 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $376,248,283 | 700,479 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $335,852,989 | 716,135 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $263,934,065 | 768,546 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $285,708,233 | 780,965 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $243,129,449 | 751,908 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $238,580,103 | 735,836 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $200,286,602 | 699,398 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $174,392,047 | 631,352 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $107,029,057 | 463,229 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $108,813,363 | 474,091 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $81,478,552 | 436,134 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $68,329,715 | 404,701 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $56,375,487 | 380,864 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $57,009,532 | 347,238 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $48,585,566 | 350,242 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||